Surgery plus speech therapy linked to improved language after stroke

Trial suggests this is a superior treatment for chronic post-stroke aphasia Combining neck surgery with intensive speech therapy is associated with greater improvements in a person's ability to communicate after a stroke than intensive speech therapy alone, finds a clinical trial published by The BMJ today. The results show improvements immediately after ...

2025-06-26T09:16:11+01:0026 June 2025|Press release, The BMJ|

BMJ finds inaccuracies in key studies for AstraZeneca’s blockbuster heart drug ticagrelor

Investigation finds evidence of serious misreporting, raising fresh doubts over the approval and decade long use of ticagrelor In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval. For more than a decade, ticagrelor ...

2025-06-20T09:46:36+01:0020 June 2025|Press release, The BMJ|

Intermittent fasting comparable to traditional diets for weight loss

May also offer other health benefits, but longer trials are needed to confirm this Intermittent fasting diets appear to have similar benefits to traditional calorie-restricted diets for weight loss, suggests an analysis of trial evidence published by The BMJ today. Alternate day fasting also demonstrates greater benefits compared with both calorie restriction ...

2025-06-19T09:39:25+01:0019 June 2025|Press release, The BMJ|

Doctors raise concern over rise in recreational ketamine use

More individuals are seeking treatment for ketamine addiction Greater awareness, research, and treatments are needed The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in The BMJ today. Irene Guerrini at South London & Maudsley NHS Foundation Trust and colleagues warn that ...

2025-06-12T10:38:40+01:0012 June 2025|Press release, The BMJ|

Humanising health: conflict, equity, and resilience

Podcasts Analysis Opinion Recordings Meeting report World Health Innovation Summit (WISH) 2024 BMJ Group partnered with the Qatar Foundation to support the World Health Innovation Summit (WISH) 2024, a leading global health event that brings together policymakers, researchers, and healthcare professionals. ...

P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease

Findings support use of P2Y12 therapy instead of aspirin for long term prevention Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding, finds a ...

2025-06-06T11:31:20+01:006 June 2025|Press release, The BMJ|
Go to Top